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Ehlers Danlos syndrome (EDS) athrocalasia type (type VII), is characterized by joint hypermobility, skin
hyperextensibility and tissue fragility. No heart involvement has been reported. Two forms have been described:
type VII A and VII B. The abnormally processed collagen α2(I) and the skipping of the exon 6 in COL1A2 gene are
typically detected in EDS type VII B. We describe a seven-year old female, with a phenotype consistent with EDS
type VII B and a diagnosis further confirmed by biochemical and molecular analyses. Cardiac ultrasound showed
normal data in the first year of life. When she was 5 years old, the patient developed mitral valve regurgitation,
and aortic and tricuspidal insufficiency at 7 years of age. To our knowledge, this is the first report of cardiac valvular
involvement in EDS VII B. This feature probably has been underreported for the limited follow-up of the patients.
Echocardiography might be warranted in the clinical assessment of EDS VII patients.
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Ehlers Danlos syndrome (EDS) is a group of inherited
connective tissue disorders. Six major forms can be dis-
tinguished on the basis of specific clinical features [1].
Over the last years, the molecular basis of several
new EDS variants have been identified; these studies
demonstrated the involvement of not only collagens
but also other ECM-related molecules in determining
EDS phenotype, refining and expanding the Villefranche
classification [2].
EDS arthrocalasia type (formerly types VIIA and B), an
autosomal dominant form, is very rare: about 40 cases
have been reported [3]. EDS type VII is due to a defect-
ive processing of type I collagen synthesis. EDS type VII
A is due to the disruption of procollagen chain α1(I),
encoded by COL1A. EDS type VII B is due to the abnor-
mality of α2(I), procollagen chain encoded by COL1A2.
The molecular defect associated with EDS type VII B
is remarkably homogeneous and result in exon 6 skip-
ping or genomic deletion of exon 6 COL1A2 gene.* Correspondence: andria@unina.it
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Commons Attribution License (http://creativec
reproduction in any medium, provided the orThe main clinical features of EDS type VII B patients
include: severe generalized hypermobility, recurrent
joints subluxations, bilateral hip dislocation. Hyperex-
tensibility of the skin, easy bruising, tissue fragility,
hypotonia, kyphoscoliosis have also been reported.
Structural cardiovascular alterations have been
described in cases of classical and hypermobile EDS [4].
Mitral valve prolapse is a manifestation of patients
affected by vascular EDS [5]. Mitral regurgitation, and
mitral valve prolapse, are reported in EDS kyphoscoliotic
type [6]. Cardiac valvular involvement has never been
reported in EDS arthrocalasia type.
We describe a seven-year and five-month old female
patient affected by EDS type VIIB and showing mitral,
aortic and tricuspidal valve regurgitation.Case report
The patient, a female, was the first child of healthy, non
consanguineous parents, with a negative family history
for genetic diseases. Foetal activity during gestation was
normal.
She was born at 40 weeks of gestation by caesarean
section, due to lack of labour progression. At birth, her
weight was 3350 g (50th centile), her length was 50 cm
(50th centile) and her head circumference was 38 cmtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Marked joint laxity at wrist and fingers is notable.
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of life, respectively. At birth, the infant showed marked
axial hypotonia, atrial septal defect, ostium secundum
type and bilateral congenital hip dysplasia, confirmed by
hip ultrasound.
At one month of age the patient was seen for the first
time in the Clinical Genetics Unit of the Department
of Paediatrics Federico II, University of Naples; phys-
ical examination, at that age, revealed macrocephaly
(40.6 cm >95th centile), which was not a familiar feature,
some dysmorphic facial features (prominent frontal bos-
sing, posteriorly rotated and low-set ears, thick lips, high
arched palate). Other clinical features included: large
anterior and posterior fontanels, bilateral patellar sub-
luxation, flat abducto-valgus deformities of the feet and
bilateral hallux valgus, bilateral hip dislocation, redun-
dant skin, especially on feet and hands, easy bruising
and axial hypotonia (Figures 1, 2, 3). The diagnosis of
EDS was suspected, therefore she underwent skin biopsy
for biochemical study.
Collagen analysis with electrophoresis of dermal colla-
gen showed an additional band migrating between the
α1 (I), and α2 (I) chains of type I collagen with mobility
of pro-α 1(I) collagen chains (pNα2(I)). The chains of
other collagens (type III and V from the patient’s cells)
were not affected. These findings were consistent with
EDS type VII B disease.
Due to biochemical study results, the genetic test for
COL1A2 was performed.
Mutation analysis of fragments encompassing intron
5 to 6 of the COL1A2, showed a T-to-C transition at
the second position T + 2 which altered the obligatory
GT nucleotide to GC (g.8984 T > C, IVS6 + 2 T > C,
Skip exon 6).
This mutation causes the skipping of the exon 6-
encoded sequences and consequently the lack of the N-
proteinase cleavage site from mutant proα chain ofFigure 1 The child at 10 years of age.type I collagen. These tests definitively confirmed the
clinical diagnosis.
Period follow-ups revealed a normal intellectual devel-
opment; a mildly delay was observed in achiving motor
milestones: she sitted up at 10 months, walked alone at
18 moths. Atrial septal defect closed spontaneously,
proved by a further echocardiography, performed when
she was three years old. An opthalmologic evaluation
was performed at 4 years, showing normal data.
When she was 5 4/12 years old, clinical examination
revealed: joint hypermobility (score of 7/9) [1], bilateral
patellar dislocations, velvety, redundant and easily stretch-
ing skin and bruising. She presented two keloids scars,
Figure 3 Joint laxity at ankle is evident.
Melis et al. Italian Journal of Pediatrics 2012, 38:65 Page 3 of 4
http://www.ijponline.net/content/38/1/65one evident in the right mandibular region, another one
in the frontal region. Auscultatory examination revealed a
midsystolic murmure. She underwent cardiac ultrasound
that reveal spontaneous closure of atrial septum defect,
but thickening of mitral valve leaflets associated with mild
mitral regurgitation. Left ventricular end-diastolic diam-
eter resulted slightly increased (37 mm, normal values of
29-35 mm). Transthoracic echocardiograms using semi-
quantitative grading of valve regurgitation, were per-
formed once a year. After two-year follow-up, combined
valvulopathy, resulting in mitral, tricuspidal and aortic re-
gurgitation, were detected. Mitral regurgitation was
graded as moderate (Jet area/Left atrium area % corres-
pond to 25%), while aortic and tricuspidal regurgitation
were defined mild. Left ventricular ejection fraction was
within normal reference (65%). Left ventricular mass
(indexed to h2.7) was 0.4, aortic root diameter (assessed
using body surface area (BSA)-adjusted) was 1.9 cm, both
in normal ranges.
Discussion
EDS VII B is a highly homogeneous syndrome. Diagnos-
tic steps remain collagen screening and molecular
analyses: pNα2(I) and the skipping of COL1A2 exon 6
respectively, yield as markers of EDS type VII B. In the
current patient pNα2(I), and a heterozygous mutation of
the COL1A2 gene IVS6 + 2 T > C (g.8984 T > C) leading
to the skipping of exon 6, were detected.
About 20 cases of EDS VII B have been previously
described in the literature, three of them share the muta-
tion IVS6 + 2 T > C.
The major clinical criteria for EDS VII B, consist in
recurrent subluxation of the joints, bilateral hip dislo-
cation and severe generalised joint hypermobility; minor
features are skin hyperextensibility, tissue fragility, easy
bruising, neonatal hypotonia, kyphoscoliosis, mild osteo-
penia [1].
The herein described patient shares with EDS VII
phenotype most of the features (generalized hypermo-
bility, recurrent subluxation of the joints, bilateral hip
dislocation, hyperextensibility of the skin and easybruising). Moreover the patient’s echocardiografic find-
ings suggest a progressive cardiac valve disease. It is
noteworthy that cardiac valvular disease has never been
described in EDS type VII.
Aortic regurgitation, mitral valve prolapse and mitral
regurgitation occur with increased frequency in patients
with Marfan syndrome, Loeys-Dietz syndrome and other
connective tissue disorders, including EDS. Cardiovascu-
lar complications (mitral valve prolapse and aortic
root dilatation) have been previously reported in indivi-
duals with EDS vascular type, hypermobile EDS, EDS
type VI [4-6].
The complete absence of proα2(I) chains, caused by
homozygosity or compound heterozygosity for COL1A2
null mutations, define a subset of EDS patients, with
hypermobility and a potential risk for cardiac valvular
disease (aortic and mitral valve regurgitation are
described), beyond the classical stigmata of EDS (skin
and joint involvement) [7,8].
Rare patients have been reported with combined
aortic, mitral and tricuspidal valve regurgitation and pro-
lapse, and the definition of “multiple floppy valves syn-
drome” has been proposed [8]. These patients, beyond
cardiac findings, show hyperextensive joints without any
other stigmata of Marfan syndrome or EDS, suggesting
an etiology due to an undefined collagen disorder [9].
These rare reports suggest that the integrity of α2(I)
collagen chains, involved in EDS VII B, is strictly neces-
sary for correct cardiac valvular development.
Type I collagen is the major fibrillar collagen, a prom-
inent protein in connective tissue. Several collagen types
as type I, III and V are expressed in heart valves leaflets
and myocardium, crosslinking themselves and with pro-
teoglycans and glycosaminoglycans [10,11].
Quantitatively minor collagens including type V colla-
gen (causally involved in classical type EDS) and type III
(implicated as a cause of vascular EDS) play an import-
ant role in type I collagen fibrillogenesis in the cardio-
vascular system [10,11].
“Multiple collagens cross-talking” is required for cru-
cial architecture and biomechanical function in heart
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changes in structure and with valvular thickening from
the aberrant collagens deposition, defective development
and failure of cardiovascular system function. A specific
disorganization of collagen fibril assembly is detected in
EDS type VII [7].
We speculate that the disruption of collagen dynamics
in cardiac valve extracellular matrix homoeostasis may
be a common mechanism resulting in valve dysfunctions.
The case reported discloses the potential cardiac
involvement in patients affected by EDS type VII B. No
further similar cases with EDS VII B have been
described; it is noteworthy that the patients, already
published with EDS type VII, did not receive a cardio-
logical follow-up.
In conclusion we describe a patient with EDS VII B
due to mutation IVS6 + 2 T > C, whose pathognomonic
manifestation (congenital hip dislocation, joint laxity,
subluxations, abnormal scars, easy bruising) have rapidly
brought to the correct diagnosis, confirming that EDS
type VII can be primarily a clinical diagnosis. Since we
demonstrated a progressive valvular involvement a care-
ful cardiac follow-up is warranted for EDS type VII
patients, because of the risk for cardiac valvular pro-
blems in early childhood.
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